Austin, United States, July 21, 2026 (GLOBE NEWSWIRE)-- The Multiplex Assays Market was valued at USD 3.31 Billion in 2025 and is projected to reach USD 8.84 Billion by 2035, expanding at a CAGR of 10 ...

Thought LeadersDr. Nicole Polinski & Dr. Elnaz AtabakhshAssociate Director of Research Programs, Senior Product ManagerMichael J. Fox Foundation & Abcam An interview with Dr. Nicole Polinski from The ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency for precision medicine research. HUSTON, TX ...

Preclinical drug discovery requires screening compound libraries that can run to hundreds of thousands of molecules against a biological target — a process where the cost per data point, the ...

Novel Immunoassay Platform for Evaluating Multiple Analytes with Minimal Sample Volume The quantitative analysis of cytokines and other analytes in plasma, serum, or cell lysate is becoming ...

This article is based on a poster originally authored by Daniel Weekes, Blaise Louis, Sunil Modi, Erica Bello, Serena Belluschi, Tom Mitchell, Holly Herbert, Tarun Vemulkar, and Jeroen Verheyen, which ...

Since the outbreak of the Covid-19 pandemic, the development of diagnostics for both the virus (molecular) and the host immune response (serological) has become essential for monitoring the spread of ...

New FluoroType® Mycobacteria PCR assay detects the mycobacteria complex and differentiates 32 clinically relevant mycobacteria species from culture, using LiquidArray® multiplex PCR technology* New ...

Boost ROI via multiplex, AI-enabled and point-of-care assays; expand personalized diagnostics and localize reagent production to reduce tariff exposure.Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- ...

LISBON, Portugal--(BUSINESS WIRE)--At the 32 nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its ...